Can 'eugenics' be defended?

Walter Veit, Jonathan Anomaly, Nicholas Agar, Peter Singer, Diana S. Fleischman, Francesca Minerva

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

In recent years, bioethical discourse around the topic of 'genetic enhancement' has become increasingly politicized. We fear there is too much focus on the semantic question of whether we should call particular practices and emerging bio-technologies such as CRISPR 'eugenics', rather than the more important question of how we should view them from the perspective of ethics and policy. Here, we address the question of whether 'eugenics' can be defended and how proponents and critics of enhancement should engage with each other.

Original languageEnglish (US)
Pages (from-to)60-67
Number of pages8
JournalMonash bioethics review
Volume39
Issue number1
DOIs
StatePublished - Jul 1 2021

All Science Journal Classification (ASJC) codes

  • Philosophy
  • Health Policy
  • Social Sciences (miscellaneous)

Keywords

  • CRISPR
  • Embryo selection
  • Enhancement
  • Ethics
  • Eugenics
  • Gene editing
  • Human enhancement

Fingerprint

Dive into the research topics of 'Can 'eugenics' be defended?'. Together they form a unique fingerprint.

Cite this